[{"address1": "3655 Nobel Drive", "address2": "Suite 260", "city": "San Diego", "state": "CA", "zip": "92122", "country": "United States", "phone": "858 926 7655", "website": "https://darebioscience.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Dar\u00e9 Bioscience, Inc. develops therapies in the areas of contraception, pelvic pain, fertility, infectious disease, menopause, and sexual and vaginal health in the United States. The company offers XACIATO, a lincosamide antibacterial gel for the treatment of bacterial vaginosis. It also develops Ovaprene, a hormone-free monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for topical administration to the female genitalia for the treatment of female sexual arousal disorder; DARE-HRT1 to treat vasomotor symptoms in menopausal hormone therapy; DARE-VVA1 for the treatment of dyspareunia or pain during sexual intercourse; and DARE-HPV, a fixed-dose formulation of lopinavir and ritonavir in a soft gel vaginal insert to treat genital human papillomavirus (HPV) infection, cervical intraepithelial neoplasia, and other HPV-related pathologies. In addition, the company develops DARE-PDM1, a hydrogel formulation of diclofenac for vaginal administration to treat primary dysmenorrhea; DARE-204 and DARE-214, injectable formulations of etonogestrel that provides contraception over 6-month and 12-month periods; DARE-FRT1, an intravaginal ring designed to deliver bio-identical progesterone for luteal phase support as part of an in vitro fertilization treatment plan; and DARE-PTB1 for the prevention of preterm birth. Further, it develops DARE-LARC1, a contraceptive implant delivering levonorgestrel with a woman-centered design controlled contraceptive option; DARE-RH1, an approach to non-hormonal contraception for men and women by targeting the CatSper ion channel; DARE-PTB2 for the prevention and treatment of idiopathic preterm birth through inhibition of a stress response protein; DARE-LBT, a vaginal thermosetting gel formulation for the delivery of live biotherapeutics; and DARE-GML, which delivers antimicrobial glycerol monolaurate intravaginally. Dar\u00e9 Bioscience, Inc. was founded in 2015 and is headquartered in San Diego, California.", "fullTimeEmployees": 21, "companyOfficers": [{"maxAge": 1, "name": "Ms. Sabrina Martucci Johnson", "age": 57, "title": "CEO, President, Principal Financial Officer, Secretary & Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 641406, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. MarDee J. Haring-Layton", "age": 48, "title": "Chief Accounting Officer", "yearBorn": 1976, "fiscalYear": 2024, "totalPay": 409800, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark  Walters", "age": 69, "title": "Vice President of Operations", "yearBorn": 1955, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Friend Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.89, "open": 1.94, "dayLow": 1.8007, "dayHigh": 1.9692, "regularMarketPreviousClose": 1.89, "regularMarketOpen": 1.94, "regularMarketDayLow": 1.8007, "regularMarketDayHigh": 1.9692, "payoutRatio": 0.0, "beta": 0.766, "forwardPE": -1.367647, "volume": 67702, "regularMarketVolume": 67702, "averageVolume": 144760, "averageVolume10days": 100930, "averageDailyVolume10Day": 100930, "bid": 1.37, "ask": 2.31, "bidSize": 2, "askSize": 2, "marketCap": 25476258, "fiftyTwoWeekLow": 1.76, "fiftyTwoWeekHigh": 9.19, "allTimeHigh": 1304.4, "allTimeLow": 1.76, "priceToSalesTrailing12Months": -1439.2552, "fiftyDayAverage": 2.0604, "twoHundredDayAverage": 2.58705, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 23069580, "profitMargins": 0.0, "floatShares": 11896604, "sharesOutstanding": 13479502, "sharesShort": 221779, "sharesShortPriorMonth": 207710, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.0165, "heldPercentInsiders": 0.11482, "heldPercentInstitutions": 0.07621, "shortRatio": 1.22, "shortPercentOfFloat": 0.0166, "impliedSharesOutstanding": 13696913, "bookValue": -1.41, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -18603688, "trailingEps": -2.16, "forwardEps": -1.36, "lastSplitFactor": "1:12", "lastSplitDate": 1719792000, "enterpriseToRevenue": -1303.293, "enterpriseToEbitda": -1.293, "52WeekChange": -0.409375, "SandP52WeekChange": 0.14261019, "quoteType": "EQUITY", "currentPrice": 1.86, "targetHighPrice": 12.0, "targetLowPrice": 8.0, "targetMeanPrice": 10.75, "targetMedianPrice": 11.5, "recommendationMean": 1.25, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 5035006, "totalCashPerShare": 0.374, "ebitda": -17844168, "totalDebt": 3032713, "quickRatio": 0.272, "currentRatio": 0.343, "totalRevenue": -17701, "revenuePerShare": -0.002, "returnOnAssets": -0.63133997, "grossProfits": -14315235, "freeCashflow": -3913925, "operatingCashflow": -11585475, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 180.7954, "financialCurrency": "USD", "symbol": "DARE", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -1.5873, "regularMarketPrice": 1.86, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1397136600000, "postMarketChangePercent": 4.3010774, "postMarketPrice": 1.94, "postMarketChange": 0.08000004, "regularMarketChange": -0.03, "regularMarketDayRange": "1.8007 - 1.9692", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 144760, "fiftyTwoWeekLowChange": 0.100000024, "fiftyTwoWeekLowChangePercent": 0.056818195, "fiftyTwoWeekRange": "1.76 - 9.19", "fiftyTwoWeekHighChange": -7.3299994, "fiftyTwoWeekHighChangePercent": -0.79760605, "fiftyTwoWeekChangePercent": -40.9375, "dividendDate": 1500508800, "earningsTimestamp": 1763067600, "earningsTimestampStart": 1763067600, "earningsTimestampEnd": 1763067600, "earningsCallTimestampStart": 1763069400, "earningsCallTimestampEnd": 1763069400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -2.16, "epsForward": -1.36, "epsCurrentYear": -1.6925, "shortName": "Dare Bioscience, Inc.", "longName": "Dar\u00e9 Bioscience, Inc.", "corporateActions": [], "postMarketTime": 1763157403, "regularMarketTime": 1763154001, "exchange": "NCM", "messageBoardId": "finmb_423979060", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "priceEpsCurrentYear": -1.098966, "fiftyDayAverageChange": -0.2004, "fiftyDayAverageChangePercent": -0.097262666, "twoHundredDayAverageChange": -0.72704995, "twoHundredDayAverageChangePercent": -0.28103438, "priceToBook": -1.319149, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "marketState": "CLOSED", "displayName": "Dar\u00e9 Bioscience", "trailingPegRatio": null, "__fetch_time": "2025-11-15"}]